JPMorgan Chase & Co’s vTv Therapeutics VTVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3
| Closed | -$52 | – | 6636 |
|
|
2025
Q1 | $52 | Sell |
3
-1,800
| -100% | -$31.2K | ﹤0.01% | 6105 |
|
|
2024
Q4 | $24.6K | Buy |
+1,803
| New | +$24.6K | ﹤0.01% | 5188 |
|
|
2024
Q3 | – | Sell |
-2
| Closed | -$35 | – | 6513 |
|
|
2024
Q2 | $35 | Hold |
2
| – | – | ﹤0.01% | 6067 |
|
|
2024
Q1 | $47 | Buy |
2
+1
| +100% | +$24 | ﹤0.01% | 6039 |
|
|
2023
Q4 | $11 | Hold |
1
| – | – | ﹤0.01% | 6373 |
|
|
2023
Q3 | $16 | Buy |
+1
| New | +$16 | ﹤0.01% | 6261 |
|
|
2021
Q3 | – | Sell |
-76
| Closed | -$7K | – | 5770 |
|
|
2021
Q2 | $7K | Sell |
76
-726
| -91% | -$66.9K | ﹤0.01% | 5256 |
|
|
2021
Q1 | $90K | Buy |
802
+142
| +22% | +$15.9K | ﹤0.01% | 4672 |
|
|
2020
Q4 | $49K | Buy |
660
+459
| +228% | +$34.1K | ﹤0.01% | 4452 |
|
|
2020
Q3 | $15K | Buy |
201
+3
| +2% | +$224 | ﹤0.01% | 4540 |
|
|
2020
Q2 | $17K | Buy |
+198
| New | +$17K | ﹤0.01% | 4445 |
|
|
2018
Q2 | – | Sell |
-8,193
| Closed | -$1.33M | – | 4856 |
|
|
2018
Q1 | $1.33M | Buy |
8,193
+2,938
| +56% | +$478K | ﹤0.01% | 2949 |
|
|
2017
Q4 | $1.26M | Buy |
5,255
+3,187
| +154% | +$766K | ﹤0.01% | 2948 |
|
|
2017
Q3 | $481K | Buy |
+2,068
| New | +$481K | ﹤0.01% | 3216 |
|
|
2017
Q2 | – | Sell |
-135
| Closed | -$35K | – | 4529 |
|
|
2017
Q1 | $35K | Sell |
135
-131
| -49% | -$34K | ﹤0.01% | 4008 |
|
|
2016
Q4 | $51K | Buy |
+266
| New | +$51K | ﹤0.01% | 4017 |
|
|
2016
Q1 | – | Sell |
-29
| Closed | -$8K | – | 4294 |
|
|
2015
Q4 | $8K | Buy |
+29
| New | +$8K | ﹤0.01% | 3664 |
|